Oral Therapy for Friedreich’s Ataxia Begins Phase 2 Trial - Research, Science, and Trials - Friedreich's Ataxia News Forums

Research, Science, and Trials

Oral Therapy for Friedreich’s Ataxia Begins Phase 2 Trial

Posted by FA Forums Moderator on March 18, 2019 at 9:11 am

Minoryx Therapeutics announced it will soon launch a Phase 2 trial in Spain to evaluate its lead therapeutic candidate, MIN-102, in patients with Friedreich’s ataxia. Click here to find out more.

What are your thoughts about this news?

Deleted User replied 5 years, 10 months ago 2 Members · 1 Reply
1 Reply

Deleted User

Deleted User
March 18, 2019 at 1:44 pm

Very good news! Thank you to everyone working!!!

Log In to Reply

Log in to reply.